Hepatitis C update: Strategies for treatment, compliance, and long-term health

American Journal of Managed Care

Volumn 11, Issue SUPPL. 10, 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

CHRONIC HEPATITIS; CONTINUING EDUCATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON METABOLISM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LONG TERM CARE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT PLANNING; UNITED STATES;

EID: 27644469956     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
2. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36(5 suppl 1):S30-S34.
3. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
4. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement-Management of Hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002;36(5 suppl 1):S3-S20.
5. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147-1171.